Urolithiasis Management Devices Market: By Device Type (Ureteroscopes, Shock Wave Lithotripters), By End User (Hospitals, Ambulatory Surgical Centers, Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Urolithiasis Management Devices Market size is valued at USD 1.57 billion in 2022 and is expected to reach USD 2.50 billion by 2028, at a significant CAGR of 4.6% from 2023-2029. Urolithiasis is the process of forming stones in the kidney, bladder, and/or urethra (urinary tract). Kidney stones are a common cause of blood in the urine and pain in the abdomen and flank. The development of the stones is related to decreased urine volume or increased excretion of stone-forming components such as calcium, oxalate, urate, cystine, xanthine, and phosphate. The stones form in the urine collecting area (the pelvis) of the kidney and may range in size from tiny to staghorn stones the size of the renal pelvis itself. In the next years, the market is expected to be boosted by an increase in the recurrence of stones and a rise in the rate of kidney stone occurrences.

Furthermore, the market would benefit from an increase in technological advancement and an improvement in the ease of detecting stones. Research and development of minimally invasive surgical methods, as well as an increase in unhealthy eating habits that include packaged foods, are projected to aid the market in gaining maximum share in the near future. However, throughout the projection period, the kidney stone management industry's growth may be hampered by a lack of understanding about surgical techniques and the availability of alternative treatment options. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Urolithiasis Management Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.6%

Largest Market

North-America

Fastest Growing Market

Europe
Urolithiasis Management Devices Market Dynamics

In the next years, the market is expected to be boosted by an increase in the recurrence of stones and a rise in the rate of kidney stone occurrences. Furthermore, the market would benefit from an increase in technological advancement and an improvement in the ease of detecting stones. Research and development of minimally invasive surgical methods, as well as an increase in unhealthy eating habits that include packaged foods, are projected to aid the market in gaining maximum share in the near future. However, throughout the projection period, the kidney stone management industry's growth may be hampered by a lack of understanding about surgical techniques and the availability of alternative treatment options.

Key Features of the Reports

  • The urolithiasis management devices market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Urolithiasis Management Devices Market Segmentation

By Type
  • Ureteroscopes
    • Rigid Ureteroscopes
    • Semi Rigid Ureteroscopes
    • Flexible Ureteroscopes
  • Shock Wave Lithotripters
    • Intracorporeal Lithotripters
      • Ultrasound Lithotripters
      • Pneumatic Lithotripters
      • Laser Lithotripters
    • Extracorporeal Lithotripters
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Geography
  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The Urolithiasis management devices market size was valued at USD 1.57 billion in 2022.

The key segments covered in the urolithiasis management devices market are technology, components, application, and end-users.

The Urolithiasis management devices market key players are Allengers (India), Boston Scientific Corporation (U.S.), BD (U.S.), Cook (U.S.), CONMED Corporation (U.S.), DirexGroup (Germany), Dornier MedTech (Germany), Karl Storz GmbH & Co. K.G. (Germany), Potent Medical (China), HealthTronics, Inc (U.S.), Olympus Corporation (Japan), EMS (Switzerland)

1.Executive Summary
2.Global Urolithiasis Management Devices Market Introduction 
2.1.Global Urolithiasis Management Devices Market  - Taxonomy
2.2.Global Urolithiasis Management Devices Market  - Definitions
2.2.1.Type
2.2.2.End User
2.2.3.Region
3.Global Urolithiasis Management Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Urolithiasis Management Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Urolithiasis Management Devices Market  By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Ureteroscopes
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Shock Wave Lithotripters
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Urolithiasis Management Devices Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Ambulatory Surgical Centers
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Urolithiasis Management Devices Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Urolithiasis Management Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Ureteroscopes
8.1.2.Shock Wave Lithotripters
8.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Ambulatory Surgical Centers
8.2.3.Others
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Urolithiasis Management Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Ureteroscopes
9.1.2.Shock Wave Lithotripters
9.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Ambulatory Surgical Centers
9.2.3.Others
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10.Asia Pacific (APAC) Urolithiasis Management Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Ureteroscopes
10.1.2.Shock Wave Lithotripters
10.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Ambulatory Surgical Centers
10.2.3.Others
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Urolithiasis Management Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Ureteroscopes
11.1.2.Shock Wave Lithotripters
11.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Ambulatory Surgical Centers
11.2.3.Others
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Urolithiasis Management Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Ureteroscopes
12.1.2.Shock Wave Lithotripters
12.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Ambulatory Surgical Centers
12.2.3.Others
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Allengers (India)
13.2.2.Boston Scientific Corporation (U.S.)
13.2.3.BD (U.S.)
13.2.4.Cook (U.S.)
13.2.5.CONMED Corporation (U.S.)
13.2.6.DirexGroup (Germany)
13.2.7.Dornier MedTech (Germany)
13.2.8.Karl Storz GmbH & Co. K.G. (Germany)
13.2.9.Potent Medical (China)
13.2.10.HealthTronics, Inc (U.S.)
13.2.11.Olympus Corporation (Japan)
13.2.12.EMS (Switzerland)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Allengers (India)
  • Boston Scientific Corporation (U.S.)
  • BD (U.S.)
  • Cook (U.S.)
  • CONMED Corporation (U.S.)
  • DirexGroup (Germany)
  • Dornier MedTech (Germany)
  • Karl Storz GmbH & Co. K.G. (Germany)
  • Potent Medical (China)
  • HealthTronics, Inc (U.S.)
  • Olympus Corporation (Japan)
  • EMS (Switzerland)

Adjacent Markets